Checkpoint Therapeutics Inc (CKPT)

$4.26 +0.03 (0.71%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	370.71M
Revenue (ttm)	40,000.00
Net Income (ttm)	-56.24M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-140,600.01%
Debt to Equity Ratio	0.00

Volume	8,666,800
Avg Vol	1,808,080
Day's Range	N/A - N/A
Shares Out	87.02M
Stochastic %K	85%
Beta	1.18
Analysts	Sell
Price Target	$4.45

Company Profile

Checkpoint Therapeutics, Inc., a commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company's lead antibody product candidate is UNLOXCYT, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers; and CK-302, a product candidate in preclinical trials for hematological malignanci...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 652 4500

Fax: 646 619 4950

Website: checkpointtx.com

Address:

95 Sawyer Road, Suite 110, Waltham, United States

Al_Paca Oct. 30 at 5:12 PM

$CKPT $ITRM quiet period can be rough

0 · Reply

H3rc1y Oct. 30 at 4:35 PM

$ITRM I am getting $CKPT PTSD… Still bullish but sometimes the lack of announcements of any short get on my nerves.

1 · Reply

sujeto Sep. 23 at 2:31 PM

$CKPT dead stock

0 · Reply

Renato17 Aug. 28 at 12:53 PM

$FBIO $FBIOP $DERM $CKPT $MBIO

0 · Reply

TREBLALBERT Aug. 25 at 4:16 PM

$CKPT

0 · Reply

SophieAllan6 Aug. 25 at 3:10 PM

$CKPT Let's keep an eye on that price target together!

0 · Reply

blackwlf Aug. 22 at 4:50 PM

$HUBC is at least 10x undervalued when compared to peers $CYBR $CKPT. It's cyber security and shorts keep forgetting it.

0 · Reply

jjangles123 Aug. 7 at 6:30 PM

$MIST Another pattern, $CKPT had CRL, steep drop, announced offering, a drop. Then the run up that resulted in PDUFA acceptance Dec 2024 doubled. Which is exactly where we are right now.

0 · Reply